ST-analysis in electronic foetal monitoring is cost-effective from both the maternal and neonatal perspective

Hooft, Janneke van ’t; Vink, Maarten; Opmeer, Brent C.; Ensing, Sabine; Kwee, Anneke; Mol, Ben Willem J.

doi:10.3109/14767058.2015.1126820

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This concurs with comparable European research. An analysis (20) based on Individual Patient Data Metaanalysis (IPDMA) (21) incorporated data from three European trials of STan monitoring (12,987 mother/baby dyads). There was consistent reduction in neonatal metabolic acidosis.…”

Section: Main Findingsmentioning

confidence: 99%

ST analysis plus CTG compared to CTG alone for intrapartum fetal monitoring (the START randomised controlled trial): A cost minimisation study.

Wilkinson,

Schubert,

Simpson

et al. 2023

Preprint

View full text Add to dashboard Cite

Objective: To undertake a cost minimisation study of ST analysis (STan) plus cardiotocograpy (CTG) compared to CTG alone. Design: Cost-minimisation analysis alongside a randomised controlled trial [(1)](#ref-0001). Setting: A tertiary level maternity centre in Adelaide, South Australia. Population: Women in labour ≥36 weeks gestation, with a clinical indication for continuous electronic fetal monitoring. Methods: We utlilised a health service perspective covering randomisation to final maternal and neonatal discharge, including readmissions. Primary analysis was intention to treat, with secondary per protocol analysis. Post hoc analyses were conducted by sub-groups and after exclusion of outliers. Main outcome measure: Average cost per mother/baby dyad. Results: Costs were calculated for 957/968 patients (98.9%) using hospital financial data. There was no statistically significant evidence of difference between the two study arms but lower costs observed in the STan arm. Average cost per mother/baby dyad was AUD12,768 for Stan+CTG, compared with AUD15,027 for CTG alone. Lower costs were mainly due to lower neonatal costs, particularly for critical care. Maternal labour cost was nearly identical in the two arms. The difference was still shown, although with reduced magnitude, when outliers were removed and increased with a per protocol analysis. Conclusion: While not statistically significant, reduced costs were observed in the CTG+STan arm (average reduction per mother / baby dyad = AUD2,259).

show abstract

Section: Main Findingsmentioning

confidence: 99%

ST analysis plus CTG compared to CTG alone for intrapartum fetal monitoring (the START randomised controlled trial): A cost minimisation study.

Wilkinson,

Schubert,

Simpson

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Despite the controversies in RCTs, many European obstetric units are now using ST analysis in clinical practice and some have published observational studies that have demonstrated a reduction in adverse perinatal outcomes. [40][41][42][43][44][45][46][47][48] Implementation of a new methodology typically requires that clinical users change their practice patterns in accordance with a set of new guidelines. However, prior to a methodology's becoming common practice, there is often a so-called learning curve, or a period of time during which experience is gathered and proficiency is attained.…”

Section: Introductionmentioning

confidence: 99%

The importance of the learning process in ST analysis interpretation and its impact in improving clinical and neonatal outcomes

Timonen

Holmberg

2018

American Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

show abstract

Practice variation in the management of intrapartum fetal distress in The Netherlands and the Western world

Bullens

Moors

Heimel

et al. 2016

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

ST-analysis in electronic foetal monitoring is cost-effective from both the maternal and neonatal perspective

Abstract: Our study suggests that STAN, when compared to EFM alone, can be a cost-effective strategy from both a maternal and neonatal perspective.

Cited by 3 publications

References 16 publications

ST analysis plus CTG compared to CTG alone for intrapartum fetal monitoring (the START randomised controlled trial): A cost minimisation study.

ST analysis plus CTG compared to CTG alone for intrapartum fetal monitoring (the START randomised controlled trial): A cost minimisation study.

The importance of the learning process in ST analysis interpretation and its impact in improving clinical and neonatal outcomes

Practice variation in the management of intrapartum fetal distress in The Netherlands and the Western world

Contact Info

Product

Resources

About